{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:11Z","timestamp":1788844211648,"version":"build-2803163510"},"reference-count":110,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Neonatal Screen.","IJNS"],"abstract":"<jats:p>Newborn screening (NBS) is a critical component of the three-tiered prevention strategy for birth defects, reducing congenital disorder burden and improving long-term child health outcomes. Over the past 45 years, NBS in China has evolved into a nationwide quality-controlled network driven by policy support and technological advances. Currently, phenylketonuria and congenital hypothyroidism are included in universal NBS across the country, and several provinces have expanded to encompass congenital adrenal hyperplasia, glucose-6-phosphate dehydrogenase deficiency, and additional inherited metabolic disorders identified through tandem mass spectrometry. The application of next-generation sequencing and other technologies has further enhanced detection capacity and expanded detectable disease spectra. Meanwhile, the National Quality Management System for NBS (QMS-NBS) has realized the visualization and standardization of screening quality and performance. Despite these advances, challenges remain, including regional disparities, inadequate follow-up, and long-term management. This review summarizes the historical evolution and policy framework of NBS in China, outlines the development of screening institutions, the spectrum and incidence of screened disorders, advances in detection technologies, and the establishment of QMS-NBS. It also highlights future priorities: expanding screened conditions, strengthening follow-up and long-term care, promoting regional equity, and advancing novel technologies to improve child health and foster precision public health.<\/jats:p>","DOI":"10.3390\/ijns12030072","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:35:29Z","timestamp":1788359729000},"page":"72","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress and Prospects of Newborn Screening in China"],"prefix":"10.3390","volume":"12","author":[{"given":"Xiaoqiang","family":"Hao","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China"},{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Hangzhou 310052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Hangzhou 310052, China"},{"name":"Department of Genetics and Metabolism, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulai","family":"Yang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Hangzhou 310052, China"},{"name":"Department of Genetics and Metabolism, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4267-9579","authenticated-orcid":false,"given":"Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Hangzhou 310052, China"},{"name":"Department of Genetics and Metabolism, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Hangzhou 310052, China"},{"name":"Department of Genetics and Metabolism, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2368-0486","authenticated-orcid":false,"given":"Zhengyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Hangzhou 310052, China"},{"name":"Department of Genetics and Metabolism, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3724\/zdxbyxb-2023-0467","article-title":"Progress of Newborn Screening in China","volume":"52","author":"Jiang","year":"2023","journal-title":"J. Zhejiang Univ. (Med. Sci.)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jalm\/jfae020","article-title":"Newborn Screening: Current Practice and Our Journey over the Last 60 Years","volume":"9","author":"Cao","year":"2024","journal-title":"J. Appl. Lab. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pcl.2017.11.013","article-title":"Newborn Screening: History, Current Status, and Future Directions","volume":"65","author":"Almannai","year":"2018","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOL.0000000000000928","article-title":"Newborn screening for lipid disorders","volume":"35","author":"Shao","year":"2024","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s44197-024-00263-z","article-title":"International Newborn Screening: Where Are We in Saudi Arabia?","volume":"14","author":"Alhusseini","year":"2024","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ajhg.2022.08.003","article-title":"A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases","volume":"109","author":"Kingsmore","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.pedneo.2022.11.001","article-title":"The modern face of newborn screening","volume":"64","author":"Chien","year":"2022","journal-title":"Pediatr. Neonatol."},{"key":"ref_8","first-page":"63","article-title":"The evolution of blood-spot newborn screening","volume":"3","author":"Bhattacharya","year":"2014","journal-title":"Transl. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jms.1528","article-title":"Mass spectrometry in newborn and metabolic screening: Historical perspective and future directions","volume":"44","author":"Chace","year":"2008","journal-title":"J. Mass Spectrom."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01799385","article-title":"Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism","volume":"13","author":"Millington","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wang, T., Ma, J., Zhang, Q., Gao, A., Wang, Q., Li, H., Xiang, J., and Wang, B. (2019). Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.01052"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41576-023-00621-w","article-title":"Genomic newborn screening for rare diseases","volume":"24","author":"Stark","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41587-025-02595-y","article-title":"Baby genomics: Newborn sequencing starts to fulfill its promise","volume":"43","author":"Sheridan","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"ref_14","first-page":"89","article-title":"Forty-three years of development of newborn screening in China: From Professor Chen Ruiguan","volume":"42","author":"Zhao","year":"2024","journal-title":"J. Clin. Pediatr."},{"key":"ref_15","unstructured":"Zhao, Z., and Gu, X. (2025). Newborn Screening, The People\u2019s Health Press Co., Ltd.. [1st ed.]."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10545-007-0687-7","article-title":"Newborn screening in the Asia Pacific region","volume":"30","author":"Padilla","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Therrell, B.L., Padilla, C.D., Abadingo, M.E., Adhikari, S.P., Aung, T., Aye, T.T., Dey, S.K., Faizi, M., Ganbaatar, E., and Giang, T.T.H. (2024). Consolidated Newborn Bloodspot Screening Efforts in Developing Countries in the Asia Pacific-2024. Int. J. Neonatal Screen., 11.","DOI":"10.3390\/ijns11010002"},{"key":"ref_18","first-page":"71","article-title":"Newborn screening: Experience of Bangladesh","volume":"34","author":"Moslem","year":"2003","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_19","unstructured":"The State Council of the People\u2019s Republic of China (2026, June 12). The Law of the People\u2019s Republic of China on Maternal and Child Health Care, Available online: https:\/\/www.gov.cn\/guoqing\/2021-10\/29\/content_5647619.htm."},{"key":"ref_20","unstructured":"The State Council of the People\u2019s Republic of China (2026, June 12). Measures for the Implementation of the Law of the People\u2019s Republic of China on Maternal and Child Health Care, Available online: https:\/\/www.nhc.gov.cn\/fzs\/c100048\/202303\/bc5e8bb6c90e4f9e9059b039736bd165.shtml."},{"key":"ref_21","unstructured":"Ministry of Health of the People\u2019s Republic of China, and China Disabled Persons\u2019 Federation (2002). China Action Plan for Improving Birth Population Quality, Reducing Birth Defects and Disabilities (2002\u20132010). Chin. J. Reprod. Health, 3, 98\u2013101. (In Chinese)."},{"key":"ref_22","unstructured":"(2005). Notice of the Ministry of Health on Issuing the Technical Specifications for Newborn Disease Screening, (In Chinese)."},{"key":"ref_23","unstructured":"(2011). Notice of the Ministry of Health on Issuing the Technical Specifications for Newborn Disease Screening, (In Chinese)."},{"key":"ref_24","unstructured":"(2009). Measures for the Management of Newborn Disease Screening, (In Chinese)."},{"key":"ref_25","unstructured":"Ministry of Health of the People\u2019s Republic of China (2010). National Plan for Newborn Disease Screening Work. Chin. J. Reprod. Health, 21, 6\u20137. (In Chinese)."},{"key":"ref_26","first-page":"1158","article-title":"Preliminary analysis of the effect of free special milk powder subsidy for children with phenylketonuria","volume":"27","author":"Liu","year":"2012","journal-title":"Matern. Child. Health Care China"},{"key":"ref_27","first-page":"290","article-title":"Clinical implementation effects of the second phase of the special milk powder subsidy project for children with phenylketonuria","volume":"18","author":"Liao","year":"2022","journal-title":"Chin. J. Obstet. Gynecol. Pediatr. (Electron. Ed.)"},{"key":"ref_28","unstructured":"National Health and Family Planning Commission, and China Disabled Persons\u2019 Federation (2026, June 12). Notice on Issuing the Program for Newborn Disease Screening Project in Poverty-Stricken Areas, Available online: https:\/\/www.nhc.gov.cn\/fys\/c100078\/201311\/6ed9ecf5086148d3afa36249118fa40d.shtml."},{"key":"ref_29","unstructured":"National Health and Family Planning Commission, and China Disabled Persons\u2019 Federation (2026, June 12). Notice on Issuing the Program for Newborn Disease Screening Project in Poverty-Stricken Areas, Available online: https:\/\/www.nhc.gov.cn\/fys\/c100078\/201412\/25b50d641b2741dda8b52d87682b1d29.shtml."},{"key":"ref_30","unstructured":"Department of Maternal and Child Health, and National Health Commission of the People\u2019s Republic of China (2026, June 12). Major Public Health Service Programs for Maternal and Child Health Progressing Smoothly, Available online: https:\/\/www.nhc.gov.cn\/fys\/c100077\/201404\/dcc2d80fbc804644a6ca44fe36a77549.shtml."},{"key":"ref_31","unstructured":"State Council of China (2016). Healthy China 2030 Planning Outline, (In Chinese)."},{"key":"ref_32","unstructured":"(2018). Notice on Issuing the National Comprehensive Prevention and Treatment Program for Birth Defects, (In Chinese)."},{"key":"ref_33","unstructured":"(2023). Notice of the General Office of the National Health Commission on Issuing the Plan for Enhancing Birth Defect Prevention and Treatment Capacity (2023\u20132027), (In Chinese)."},{"key":"ref_34","unstructured":"The Standing Committee of the Beijing Municipal People\u2019s Congress (2026, June 12). Beijing Municipal Implementation Measures for the Law of the People\u2019s Republic of China on Maternal and Child Health Care, Available online: https:\/\/www.beijing.gov.cn\/zhengce\/dfxfg\/202103\/t20210313_2306735.html."},{"key":"ref_35","unstructured":"The Standing Committee of the Beijing Municipal People\u2019s Congress (2026, June 12). Shanghai Municipal Maternal and Child Health Care Regulations, Available online: https:\/\/wsjkw.sh.gov.cn\/fg2\/20180525\/0012-31553.html."},{"key":"ref_36","unstructured":"The Standing Committee of the Beijing Municipal People\u2019s Congress (2026, June 12). Sichuan Provincial Implementation Measures for the Law of the People\u2019s Republic of China on Maternal and Child Health Care, Available online: https:\/\/www.scspc.gov.cn\/flfgk\/scfg\/200206\/t20020625_12530.html."},{"key":"ref_37","unstructured":"Health Commission of Guangdong Province (2019). Administrative Measures for Newborn Disease Screening in Guangdong Province, (In Chinese)."},{"key":"ref_38","unstructured":"Office of the Health Commission of Zhejiang Province (2026, June 12). Notice on the Issuance of Zhejiang Province Newborn Disease Screening Project Implementation Plan (2023 Edition), Available online: https:\/\/zjjcmspublic.oss-cn-hangzhou-zwynet-d01-a.internet.cloud.zj.gov.cn\/jcms_files\/jcms1\/web2760\/site\/attach\/0\/0a213c2c7a814d7d982439aef31ffa39.pdf."},{"key":"ref_39","unstructured":"(2023). Neonatal Inherited Metabolic Disease Screening Group; Birth Defect Prevention and Control Professional Committee; Chinese Preventive Medicine Association. Expert Consensus on Organizational Management and Dried Blood Spot Collection for Neonatal Inherited Metabolic Disease Screening. Chin. J. Neonatol., 38, 321\u2013326. (In Chinese)."},{"key":"ref_40","unstructured":"Department of Medical Administration, and National Health Commission of the People\u2019s Republic of China (2026, August 11). Notice of the Ministry of Health on Issuing the \u201cAdministrative Measures for Clinical Laboratories in Medical Institutions\u201d, Available online: https:\/\/www.nhc.gov.cn\/yzygj\/c100068\/200603\/508cbe26295944c0a1ed2999b25ee375.shtml."},{"key":"ref_41","unstructured":"China National Accreditation Service for Conformity Assessment (2026, August 11). Application Requirements of Accreditation Criteria for the Quality and Competence of Medical Laboratories. Available online: https:\/\/www.cnas.org.cn\/rkgf\/sysrk\/rkyyzz\/art\/2024\/art_9a46afffeaa144c8b2e065f691045aea.html."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0969141315592924","article-title":"Neonatal screening external quality assessment in China, 2014","volume":"22","author":"Zhong","year":"2015","journal-title":"J. Med. Screen."},{"key":"ref_43","first-page":"1182","article-title":"National external quality assessment of quality indicators for newborn inherited metabolic disease screening","volume":"25","author":"Wang","year":"2017","journal-title":"Chin. J. Child. Health Care"},{"key":"ref_44","unstructured":"(2023). Conformity Assessment\u2014General Requirements for the Competence of Proficiency Testing Providers (Standard No. ISO\/IEC 17043:2023)."},{"key":"ref_45","unstructured":"China National Accreditation Service for Conformity Assessment (2024). CNAS-CL03:2024 Accreditation Criteria for Proficiency Testing Providers."},{"key":"ref_46","unstructured":"(2022). Medical Laboratories-Requirements for Quality and Competence (Standard No. ISO 15189:2022)."},{"key":"ref_47","first-page":"411","article-title":"Evaluation and optimization suggestions for the consensus on quality indicators for newborn inherited metabolic disease screening","volume":"46","author":"Wang","year":"2023","journal-title":"Shanghai Med. J."},{"key":"ref_48","unstructured":"Expert Group on Newborn Inherited Metabolic Disease Screening Laboratories, and National Center for Clinical Laboratories (2017). Consensus on quality indicators for newborn inherited metabolic disease screening. Chin. J. Lab. Med., 40, 352\u2013355. (In Chinese)."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/CM9.0000000000002386","article-title":"Quality management of the newborn screening network: The Chinese experience","volume":"136","author":"Jin","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_50","unstructured":"Zhao, Z., and Gu, X. (2015). Newborn Genetic Metabolic Diseases Screening, The People\u2019s Health Press Co., Ltd.. [1st ed.]."},{"key":"ref_51","unstructured":"Zhao, Z., Zhou, W., and Liang, D. (2022). Newborn Genetic Screening, The People\u2019s Health Press Co., Ltd.. [1st ed.]."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e031474","DOI":"10.1136\/bmjopen-2019-031474","article-title":"Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: A descriptive study","volume":"9","author":"Xiang","year":"2019","journal-title":"BMJ Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/CM9.0000000000001613","article-title":"Geographic variations in the incidence of congenital hypothyroidism in China: A retrospective study based on 92 million newborns screened in 2013-2018","volume":"134","author":"Yao","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1007\/s00431-023-05108-8","article-title":"Increased incidence of congenital hypothyroidism in China: An analysis of 119 million screened newborns","volume":"182","author":"Yao","year":"2023","journal-title":"Eur. J. Pediatr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.23911","article-title":"Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017","volume":"41","author":"Liu","year":"2019","journal-title":"Hum. Mutat."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Li, Z., Huang, L., Du, C., Zhang, C., Zhang, M., Liang, Y., and Luo, X. (2021). Analysis of the Screening Results for Congenital Adrenal Hyperplasia Involving 7.85 Million Newborns in China: A Systematic Review and Meta-Analysis. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.624507"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Shi, X.T., Cai, J., Wang, Y.Y., Tu, W.J., Wang, W.P., Gong, L.M., Wang, D.W., Ye, Y.T., Fang, S.G., and Jing, P.W. (2013). Newborn Screening for Inborn Errors of Metabolism in Mainland China: 30 Years of Experience, Springer. JIMD Reports.","DOI":"10.1007\/8904_2011_119"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0969141320973690","article-title":"Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: A census of over seven million newborns between 2016 and 2017","volume":"28","author":"Deng","year":"2020","journal-title":"J. Med. Screen."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108098","DOI":"10.1016\/j.ymgme.2023.108098","article-title":"Screening of 1.17 million newborns for inborn errors of metabolism using tandem mass spectrometry in Shanghai, China: A 19-year report","volume":"141","author":"Hao","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"ref_60","first-page":"765","article-title":"Quality evaluation of tandem mass spectrometry screening for neonatalinherited metabolic diseases in Zhejiang Province from 2009 to 2021","volume":"34","author":"Chen","year":"2022","journal-title":"Prev. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e2152","DOI":"10.1002\/mgg3.2152","article-title":"Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7-year study in eastern coastal areas of China","volume":"11","author":"Men","year":"2023","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cca.2019.12.022","article-title":"Newborn screening and diagnosis of inborn errors of metabolism: A 5-year study in an eastern Chinese population","volume":"502","author":"Yang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2019.03.1622","article-title":"Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population","volume":"494","author":"Lin","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3724\/zdxbyxb-2021-0260","article-title":"Screening for neonatal inherited metabolic disorders by tandem mass spectrometry in Guangzhou","volume":"50","author":"Tang","year":"2021","journal-title":"J. Zhejiang Univ. (Med. Sci.)"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zhang, H., Tian, H., Dai, W., Zhang, L., Guo, G., and Ding, G. (2025). Expanded newborn screening for inborn errors of metabolism and genetic variants in Xinjiang, China. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1617418"},{"key":"ref_66","first-page":"1","article-title":"Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Xiao, G., Feng, Z., Xu, C., Huang, X., Chen, M., Zhao, M., Li, Y., Gao, Y., Wu, S., and Shen, Y. (2024). 206,977 newborn screening results reveal the ethnic differences in the spectrum of inborn errors of metabolism in Huaihua, China. Front. Genet., 15.","DOI":"10.3389\/fgene.2024.1387423"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, X., He, J., He, L., Zeng, Y., Huang, X., Luo, Y., and Li, Y. (2022). Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.763222"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-025-01483-z","article-title":"Effect of newborn genomic screening for lysosomal storage disorders: A cohort study in China","volume":"17","author":"Wang","year":"2025","journal-title":"Genome Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Li, R., Tian, L., Gao, Q., Guo, Y., Li, G., Li, Y., Sun, M., Yan, Y., Li, Q., and Nie, W. (2022). Establishment of Cutoff Values for Newborn Screening of Six Lysosomal Storage Disorders by Tandem Mass Spectrometry. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.814461"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e2410754","DOI":"10.1001\/jamanetworkopen.2024.10754","article-title":"Newborn Screening for 6 Lysosomal Storage Disorders in China","volume":"7","author":"Chang","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2022.11.024","article-title":"Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China","volume":"539","author":"Jia","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e11071","DOI":"10.1016\/j.heliyon.2022.e11071","article-title":"A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou","volume":"8","author":"Jia","year":"2022","journal-title":"Heliyon"},{"key":"ref_74","first-page":"258","article-title":"Screening for Duchenne muscular dystrophy in newborns in the Ningxia region","volume":"26","author":"Jing","year":"2024","journal-title":"Chin. J. Contemp. Pediatr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12519-017-0036-3","article-title":"Newborn screening for Duchenne muscular dystrophy in China: Follow-up diagnosis and subsequent treatment","volume":"13","author":"Ke","year":"2017","journal-title":"World J. Pediatr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s12519-024-00846-7","article-title":"Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: The Chinese experience","volume":"20","author":"Chen","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"117653","DOI":"10.1016\/j.cca.2023.117653","article-title":"A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population","volume":"552","author":"Tang","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Chiang, S.-C., Chen, P.-W., Hwu, W.-L., Lee, A.-J., Chen, L.-C., Lee, N.-C., Chiou, L.-Y., and Chien, Y.-H. (2018). Performance of the Four-Plex Tandem Mass Spectrometry Lysosomal Storage Disease Newborn Screening Test: The Necessity of Adding a 2nd Tier Test for Pompe Disease. Int. J. Neonatal Screen., 4.","DOI":"10.3390\/ijns4040041"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Burlina, A.B., Polo, G., Rubert, L., Gueraldi, D., Cazzorla, C., Duro, G., Salviati, L., and Burlina, A.P. (2019). Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5020024"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Priestley, J.R.C., Adang, L.A., Williams, S.D., Lichter-Konecki, U., Menello, C., Engelhardt, N.M., DiPerna, J.C., DiBoscio, B., Ahrens-Nicklas, R.C., and Edmondson, A.C. (2022). Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8020024"},{"key":"ref_81","first-page":"100902","article-title":"High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan","volume":"32","author":"Chen","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.21037\/atm-20-1147","article-title":"A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: Results from 1,127 newborns","volume":"8","author":"Luo","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Tang, C., Li, L., Chen, T., Li, Y., Zhu, B., Zhang, Y., Yin, Y., Liu, X., Huang, C., and Miao, J. (2024). Newborn Screening for Inborn Errors of Metabolism by Next-Generation Sequencing Combined with Tandem Mass Spectrometry. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10020028"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e2331162","DOI":"10.1001\/jamanetworkopen.2023.31162","article-title":"Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12519-022-00670-x","article-title":"A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China","volume":"19","author":"Yang","year":"2023","journal-title":"World J. Pediatr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jgg.2021.08.008","article-title":"Newborn screening with targeted sequencing: A multicenter investigation and a pilot clinical study in China","volume":"49","author":"Hao","year":"2021","journal-title":"J. Genet. Genom."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"04128","DOI":"10.7189\/jogh.13.04128","article-title":"Newborn genetic screening is highly effective for high-risk infants: A single-centre study in China","volume":"13","author":"Wang","year":"2023","journal-title":"J. Glob. Health"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.ajhg.2024.10.021","article-title":"Prequalification of genome-based newborn screening for severe childhood genetic diseases through federated training based on purifying hyperselection","volume":"111","author":"Kingsmore","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.ajhg.2024.10.020","article-title":"Ge-nome-based newborn screening for severe childhood genetic diseases has high positive predictive value and sensitivity in a NICU pilot trial","volume":"111","author":"Kingsmore","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.2024.19662","article-title":"Expanded Newborn Screening Using Genome Sequencing for Early Actionable Conditions","volume":"333","author":"Ziegler","year":"2024","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41591-024-03465-x","article-title":"Population-based, first-tier genomic newborn screening in the maternity ward","volume":"31","author":"Boemer","year":"2025","journal-title":"Nat. Med."},{"key":"ref_92","unstructured":"Writing Group for Clinical Practice Guidelines for Genetic Diseases, Chinese Society of Medical Genetics, Huang, S.Z., and Song, F. (2020). Clinical practice guidelines for phenylketonuria. Chin. J. Med. Genet., 37, 226\u2013234. (In Chinese)."},{"key":"ref_93","unstructured":"Chinese Fabry Disease Expert Collaborative Group (2021). Expert consensus on diagnosis and treatment of Fabry disease in China (2021 edition). Chin. J. Intern. Med., 60, 321\u2013330. (In Chinese)."},{"key":"ref_94","unstructured":"NeuroScience Professional Committee, Chinese Research Hospital Association, and Special Fund Expert Group for Neuromuscular Disease Prevention and Control, China Birth Defects Intervention and Assistance Foundation (2023). Expert consensus on newborn screening for spinal muscular atrophy (2023 edition). Natl. Med. J. China, 103, 2075\u20132081. (In Chinese)."},{"key":"ref_95","unstructured":"Working Group on Guidelines for Diagnosis and Treatment of Congenital Hypothyroidism, Chinese Society of Endocrinology, and Chinese Pediatric Society (2025). Guidelines for diagnosis and treatment of congenital hypothyroidism. Chin. J. Endocrinol. Metab., 41, 267\u2013289. (In Chinese)."},{"key":"ref_96","first-page":"488","article-title":"Expert consensus on biological sample management for newborn disease screening","volume":"38","author":"Zhuang","year":"2020","journal-title":"J. Clin. Lab. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12519-022-00522-8","article-title":"Application of next generation sequencing in the screening of monogenic diseases in China, 2021: A consensus among Chinese newborn screening experts","volume":"18","author":"Tong","year":"2022","journal-title":"World J. Pediatr."},{"key":"ref_98","unstructured":"Neonatal Inherited Metabolic Disease Screening Group, Birth Defect Prevention and Control Professional Committee, Chinese Preventive Medicine Association, National Committee for External Quality Assessment of Neonatal Inherited Metabolic Disease Screening, and National Center for Clinical Laboratories (2023). Expert consensus on laboratory testing technical guidelines for neonatal inherited metabolic disease screening. Chin. J. Neonatol., 38, 449\u2013454. (In Chinese)."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12519-025-00996-2","article-title":"Expert consensus on the combined screening of genes and biomarkers for neonatal diseases","volume":"22","author":"Huang","year":"2025","journal-title":"World J. Pediatr."},{"key":"ref_100","unstructured":"National Committee for External Quality Assessment of Neonatal Inherited Metabolic Disease Screening, National Center for Clinical Laboratories, Ou, M.C., and Jiang, J.H. (2020). Expert consensus on follow-up of newborn screening for neonatal genetic and metabolic diseases. Chin. J. Med. Genet., 37, 367\u2013372. (In Chinese)."},{"key":"ref_101","unstructured":"(2023). Neonatal Inherited Metabolic Disease Screening Group; Birth Defect Prevention and Control Professional Committee; Chinese Preventive Medicine Association. Expert consensus on diagnosis and treatment of inherited metabolic diseases by newborn screening. Chin. J. Neonatol., 38, 385\u2013394. (In Chinese)."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-022-02474-8","article-title":"Current attitudes and preconceptions on newborn genetic screening in the Chinese reproductive-aged population","volume":"17","author":"Wang","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_103","unstructured":"The People\u2019s Government of Kunshan City (2026, June 12). Notice on the Issuance of the Implementation Plan for the Free Screening Project of 29 Genetic Metabolic Diseases for Newborns with Household Registration in Kunshan City, Available online: https:\/\/www.ks.gov.cn\/kss\/c113206puf\/201604\/f1543901862145b8ac3e0bf5cc957041.shtml."},{"key":"ref_104","unstructured":"The People\u2019s Government of Kunshan City (2026, June 12). Fucheng Has Launched a Public Welfare Project to Subsidize the Screening of 48 Genetic Metabolic Diseases for Newborns, Available online: https:\/\/www.my.gov.cn\/mysrmzf\/c100089\/202506\/0cf335f10a6845dca7f91d6ae10e660d.shtml."},{"key":"ref_105","unstructured":"The People\u2019s Government of Sichuan Province (2025). The Free Genetic Metabolic Disease Screening for Newborns in Chengdu Has Benefited over 100,000 People This Year, Sichuan Provincial Government News Release."},{"key":"ref_106","unstructured":"Xiangtan Municipal Finance Bureau, Xiangtan Municipal Health Commission (2026, June 12). Notice on Allocating Funds for the 2024 Key Livelihood Project of Free Neonatal Disease Screening and Diagnosis by the Provincial Government, Available online: https:\/\/cz.xiangtan.gov.cn\/2419\/25302\/content_1334430.html."},{"key":"ref_107","unstructured":"Gongqingcheng Municipal Health Commission (2026, June 12). Gongqingcheng Municipal Health Commission Has Compiled the 2024 Departmental Budget, Available online: https:\/\/www.gongqing.gov.cn\/zwgk\/wugongkai\/glgk\/03\/02\/24\/202402\/t20240223_6415580.html."},{"key":"ref_108","first-page":"106","article-title":"Current situation and prospects of newborn screening and treatment for Phenylketonuria in China\u2014Compared with the current situation in the United States, UK and Japan","volume":"2","author":"Mei","year":"2014","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_109","unstructured":"National Healthcare Security Administration (2026, June 12). What Are the Benefits for Newborns When They Enroll in Insurance?, Available online: https:\/\/www.nhsa.gov.cn\/art\/2025\/7\/16\/art_14_17289.html."},{"key":"ref_110","unstructured":"China Birth Defects Intervention Assistance Foundation (2026, June 12). Central Special Lottery Public Welfare Fund Project. Available online: https:\/\/www.csqx.org.cn\/list.aspx?id=580303611982."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/3\/72\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:24:36Z","timestamp":1788841476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/3\/72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":110,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijns12030072"],"URL":"https:\/\/doi.org\/10.3390\/ijns12030072","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}